Back to Search Start Over

Bevacizumab (BV) in combination with folfoxiri (irinotecan, oxaliplatin and infusional 5FU/LV) in metastatic colorectal cancer (MCRC): updates results of a phase II G.O.N.O. trial

Details

Language :
English
Database :
OpenAIRE
Journal :
Università di Pisa-IRIS
Accession number :
edsair.dedup.wf.001..cb5a1c8e8f509d02e92105e4b9cd7fd9